Novanta Inc

Análisis de la acción Novanta Inc (NOVT)

$142.200

-2.403 (-1.69%)Al cierre

Loading chart…
High
146.310
Open
145.780
VWAP
143.16
Vol
265.47K
Mkt Cap
Low
140.970
Amount
38.00M
EV/EBITDA, TTM
23.68

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.

AI analysis of Novanta Inc (NOVT)

hold

Currently, Novanta Inc. (NOVT) is trading at $142.20, which is below the analyst price target of $194, indicating potential upside. However, the RSI is at a low 33.05, suggesting the stock is oversold and may not be a strong buy at this moment. The main risk is the insider selling activity, which has increased by 134.30% over the last month, indicating potential concerns from insiders about the stock's future performance.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 142.20
Mínimo
Promedio
Máximo

Baird

2026-08-07

Precio objetivo

$194

Outperform

Baird

2026-05-13

Precio objetivo

$173

Outperform

Baird

2026-03-30

Precio objetivo

$144

Outperform

Baird

2026-02-25

Precio objetivo

$150

Neutral

Baird

2025-08-11

Precio objetivo

$133

Neutral

Métricas de valoración

The current forward P/E ratio for Novanta Inc (NOVT) is 8.39, compared to its 5-year average forward P/E of 40.80.

Forward P/E

Strongly Undervalued
5Y Average P/E
40.80
Current P/E
8.39
Sobrevalorada
55.13
Infravalorada
26.47

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
27.22
Current EV/EBITDA
23.68
Sobrevalorada
31.77
Infravalorada
22.67

Forward P/S

Undervalued
5Y Average P/S
5.53
Current P/S
4.17
Sobrevalorada
6.52
Infravalorada
4.54

Alphio AI Price Scenarios for NOVT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NOVT

$155.23

Precio del escenario

B

Base

Base · 50%NOVT

$145.52

Precio del escenario

B

Bear

Bear · 25%NOVT

$116.12

Precio del escenario

Whales holding NOVT

G

Greenhouse Funds LLLP

+ HoldingNOVT

+9.14%

3M Return

D

D.F. Dent and Company, Inc.

+ HoldingNOVT

+5.94%

3M Return

A

Allspring Global Investments, LLC

+ HoldingNOVT

+0.98%

3M Return

D

Delaware Management Company

+ HoldingNOVT

-0.03%

3M Return

C

Congress Asset Management Company, LLP

+ HoldingNOVT

-2.69%

3M Return

Cronología de eventos

2026-08-05 (ET)

17:00:00

Sees FY26 Revenue of $1.13B-$1.14B

17:00:00

Novanta Reports Q2 Revenue of $265.8 Million

17:00:00

Sees Q3 Revenue of $300M-$304M

2026-07-27 (ET)

08:30:00

Novanta Completes Acquisition of Riverpoint Medical

2026-06-29 (ET)

17:30:00

Selling Stockholders Plan to Sell 2.14M Common Shares

Noticias

NOVT FAQ — answered by Alphio AI

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others. It operates in the Technology sector (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SU industry).

Currently, Novanta Inc. (NOVT) is trading at $142.20, which is below the analyst price target of $194, indicating potential upside. However, the RSI is at a low 33.05, suggesting the stock is oversold and may not be a strong buy at this moment. The main risk is the insider selling activity, which has increased by 134.30% over the last month, indicating potential concerns from insiders about the stock's future performance.

1 analysts cover NOVT: 1 rate it Buy, 0 Hold and 0 Sell.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis